Shin Eonwoo, Sung Changhwan, Son Hye Joo, Lee Dong Yun, Chae Sun Young, Moon Dae Hyuk
Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympicro 43-gil, Songpa-gu, Seoul 05505 Republic of Korea.
Nucl Med Mol Imaging. 2019 Aug;53(4):270-277. doi: 10.1007/s13139-019-00595-w. Epub 2019 May 27.
This study aimed to determine the diagnostic value of the relative filtration fraction (RFF) assessed by dynamic Tc-diethylenetriaminepentaacetic acid (Tc-DTPA) renal scintigraphy after angiotensin-converting enzyme (ACE) inhibition for renovascular hypertension (RVHT) diagnosis.
Tc-DTPA captopril renal scintigraphy performed in adolescents or adults (≥ 10 years) with suspected RVHT was retrospectively reviewed. The RFF of the affected kidney was qualitatively assessed as the relative glomerular filtration rate during the 2 to 3-min period compared with the relative perfusion during the first 60 s (qualitative RFF) and scored from 1 (definitely same) to 5 (definitely decreased). The quantitative RFF of the affected kidney was obtained by dividing the percentage of glomerular filtration rate by the percentage of renal perfusion.
Overall, 173 patients (high probability, = 15; and low probability, = 158) were included based on conventional captopril renal scintigraphic criteria. An abnormal qualitative RFF was observed in 12 patients with high probability, and the diagnostic sensitivity was 80.0% (95% CI, 51.9-95.7). The RFF was normal in 152 patients with low probability, and the diagnostic specificity was 96.2% (95% CI, 91.9-98.6). The RFF was lower in patients with high probability than in those with low probability (0.79 ± 0.15 vs. 1.02 ± 0.11, < 0.0001).
The RFF assessed by dynamic Tc-DTPA renal scintigraphy after ACE inhibition can detect patients with high probability for RVHT. The RFF after ACE inhibition might be a useful diagnostic criterion especially when baseline scintigraphy is not available for evaluating ACE inhibition-induced changes.
本研究旨在确定血管紧张素转换酶(ACE)抑制后,通过动态锝-二乙三胺五乙酸(Tc-DTPA)肾闪烁显像评估的相对滤过分数(RFF)对肾血管性高血压(RVHT)诊断的价值。
回顾性分析对疑似RVHT的青少年或成人(≥10岁)进行的Tc-DTPA卡托普利肾闪烁显像。将患肾的RFF定性评估为2至3分钟期间的相对肾小球滤过率与最初60秒期间的相对灌注相比(定性RFF),并从1(肯定相同)到5(肯定降低)进行评分。患肾的定量RFF通过将肾小球滤过率百分比除以肾灌注百分比获得。
总体而言,根据传统的卡托普利肾闪烁显像标准,纳入了173例患者(高概率,=15;低概率,=158)。12例高概率患者观察到定性RFF异常,诊断敏感性为80.0%(95%CI,51.9-95.7)。152例低概率患者的RFF正常,诊断特异性为96.2%(95%CI,91.9-98.6)。高概率患者的RFF低于低概率患者(0.79±0.15对1.02±0.11,<0.0001)。
ACE抑制后通过动态Tc-DTPA肾闪烁显像评估的RFF可检测出RVHT高概率患者。ACE抑制后的RFF可能是一种有用的诊断标准,尤其是在无法获得基线闪烁显像来评估ACE抑制诱导的变化时。